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We have reported that a product of mouse thymus, prepared according to the 
method  of  Goldstein et  al.  for  extracting "thymosin"  (1),  induces precursor 
cells found in the spleen and bone marrow of adult mice to differentiate in vitro 
into T  lymphocytes, defined as cells expressing the T  lymphocyte antigens TL, 
Thy-1,  and Ly,  within about 2  h  (2).  (We have avoided calling the inducer 
thymosin in case these may be different products occurring in the same prepa- 
ration.) The simplest interpretation is that the noninduced precursor cell has 
not passed  through  the  thymus, but would or could in the normal course of 
events do so, and thereby become differentiated into a T  lymphocyte. (Whether 
these precursor cells are as yet uncommitted to T  lymphocyte differentiation 
or are already primed or genetically "determined" to respond to the T  lympho- 
cyte thymic inducer is unknown.) While many interesting points can be raised 
regarding this in vitro induction system, we shall consider here only this one 
question: Is the inducible cell truly a precursor that has not yet undergone any 
thymus-mediated process? To answer this we have tested  the inducibility of 
cells from the spleen and bone marrow of nu,/nu mice (which lack a  thymus) 
and from the liver of embryonic mice. 
Materials and Methods 
Mice.--All mice, including the congenic stocks A/Thy-l.1 (formerly called A/0-AKR) and 
A/TL-, were bred in our own colonies.  The nu/nu mice come from a stock that has undergone 
four to five backcrosses to BALD/c; the -~/nu mice were heterozygotes of this line; the nu/nu 
mice were bred and maintained under normal conditions without protection from environ- 
mental infection. 
Induction P~vcedure.--The  procedure of Goldstein et al. for thymosin (1) was used to pre- 
pare "thymic extract"  from thymuses of TL-negative mice and "splenic extract"  (for con- 
trol) ; the final preparations had approximately equivalent protein concentrations (OD/280 nm 
0.5 U/ml for thymus and 0.7 for spleen) and were used undiluted. 
Cells from spleen, bone marrow, or embryonic liver (separated by teasing) were fractionated 
by centrifugation on gradients of bovine serum albumin (BSA) yielding four layers: A (10- 
23% BSA interface), B (23  26%), C (26-29%), and D (29~5%). Three aliquots of cells from 
each layer were incubated with (a) thymic extract, (b) splenic extract (control), and (c) without 
extract  (control), for 2 h at 37°C. (Meanwhile, cytotoxicity tests with Thy-1 antiserum were 
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carried out on a  fourth aliquot,  to ascertain  the number  of T  lymphocytes  present in untreated 
cells  of  each  layer,  data  shown  in  Table  II.)  After  the  2-h  incubation  period  the  cells  were 
washed  and  tested for Thy-1  or TL  antigens  in cytotoxicity  tests with antiserum  (prepared in 
our congenic mouse  strains)  diluted  1/10 and  1/20  (the two dilutions always gave very similar 
results). The  formula used in Table  I  gives the proportion  of cells expressing Thy-1  or TL  anti- 
gen in consequence  of exposure  to the extract.  More  complete  technical details,  and references 
to methods,  will be found in our previous report  (2). 
RESULTS AND  DISCUSSION 
The data are summarized in Tables I  and  II. As before  (2),  the inducible 
precursor cells were found in the A  and B  layers of spleen  and bone marrow 
(Table I)  and  preexisting T  lymphocytes in  the  C  and D  layers  (Table II). 
Induction of Cells  from nu/nu Mice.--Table I  shows that thymic extract in- 
TABLE I 
D~erentiation  of Thy-1 + or TL  + Cells Induced In Vitro by a Produvt of the Thymus.  Positive Results with Cells from 
Adult  Bone Marrow,  Spleen  and Bone Marrow of nu/nu  Mice,  and Fetal  Liver 
Mouse strain  Cells from  Antiserum 
Thy-t  + or TL  + cells (%)* induced in layer 
A  B  C  I) 
A/Thy-IA  Bone marrow  Anti-Thy-l.t  28  (-1){;  26  (7)  1  (3)  -- 
Anti-Thy-l.2§  t  (0)  0  (3)  --  -- 
Anti-TL  30  (8)  27  (4)  5  (4)  -- 
A/TL  Anti-TL§  4  (5)  3  (2)  -- 
nu/nu  Spleen  Anti-Thy- 1.2  31  (0)  34  (-4)  -4  (2)  - 
Anti-Thy-l.l§  --1  (0)  --2  (--1)  --2  (.5)  -- 
Bone marrow  Anti-Thy-l.2  35  (3)  16  (4)  --2  (--3)  -1  (-2) 
Anti-Thy-l.l§  --3  (0)  --4  (--2)  --  -- 
..{-/nu  Spleen  Anti-Thy-l.2  24  (3)  25  (6)  -2  (-2)  - 
Anti-Thy-l.l§  1  (2)  3  (3)  --  -- 
Fetal liver (18  Anti-Thy-l.2  --  27  (3)  4  (-I)  5  (2) 
days)  Anti-Thy-l.l§  --4  (1)  1  (2)  -- 
Anti-TL  26  (--1)  13  (3)  4  (2) 
Fetal liver (14  Anti-Thy-l.2  ]  27  (4)  4  (4)  -1  (--2) 
days)  Anti-Thy-l.l§  --5  (--1)  2  (2)  -- 
Anti-TL  34  (4)  7  (0)  3  (1) 
a--b 
* Calculation: 100 X 
a 
a  =  %  cells viable in eytotoxieity t est after preincubation without extract; 
b =  % cells viable in cytotoxiclty test after preincubation with thymic extract or splenic (control) extract. 
This formula gives the percent of newly induced Thy-1  + or TL  + cells, excluding those already present in the 
starting population. 
Numbers in parentheses are the control values for cells preincubated with splenic extract in place of thymic 
extract, the two extracts being prepared in the same way and having approximately the same protein concentra- 
tions. 
§ Negative control. 
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duced  Thy-l-positive  cells  from  spleen  and  bone  marrow  of  nu/nu  mice  in 
numbers  even higher than  for normal  mice  (35 %  of nu/nu A  layer bone mar- 
row  cells).  Clearly  there  is  no  lack  of  inducible  T  lymphocyte  precursors  in 
mice that lack a  thymus. 
No T  lymphocytes  were demonstrable  in untreated  spleen  or bone  marrow 
of nu/nu mice (Table II). Reported demonstrations  of Thy-1  antigen in nu/nu 
mice by serological absorption  (3)  do not necessarily indicate  that nu/nu mice 
have  some T  lymphocytes,  because  Thy-1  antigen  is  expressed  on  epidermal 
cells  and  brain  of  nu/nu  mice,  and  Thy-1  antigen  is  probably  present  on 
another  cell  type  that  may  be  present  in  hemopoietic  tissues  (unpublished 
work  of  Dr.  M.  Scheid  in  this  laboratory).  Absence  of  T  lymphocytes  from 
TABLE  II 
Proportion of Cells Recovered in  Each Layer, and Proportion of Preexisting Thy-l-Positlve 
(Th ¢-1+)  * Cells within Each Layer* 
Mouse strain 
A/Thy-l.1 
A/TL- 
~lu/nz¢ 
Cells from 
Bone marrow 
Spleen 
Bone marrow 
Spleen 
Fetal liver 
(18 days) 
Fetal liver 
(14 days 
Yield§ 
5-12 
8-15 
10-18 
5  10 
6  10 
7  13 
5-10 
Thy-1 + 
cells 
% 
<5 
<5 
<5 
<5 
<5  +/nu 
A 
Yield 
30-35 
34-38 
25-32 
,540 
5-20 
2-20 
8-15 
L 
Cell layer 
B 
Thy-1  +  ceils  Yield 
% 
<5  13  20 
<5  15-20 
<5  10-15 
<5  28  34 
5-10  25-30 
<5  10-20 
<5  10-15 
c  D 
Thy-I  +  Thy-1  +  cells  Yield  cells 
%  % 
<5  13-18  10-20 
<5  10-15  15  20 
<5  5-10 
<5  2-5 
30-40  20-25 
<5i  5-8 
<5  5-10 
<5 
<5 
45-55 
<5 
<5 
* Determined on cells of each layer immediately after their recovery from the BSA gradi- 
a--b 
ent. Calculation: 100 X  a 
a  =  %  cells viable in  cytotoxicity test  control  with  complement  added  but  antiserum 
omitted; 
b  =  %  cells viable in cytotoxicity test with antiserum and complement: (anti-Thy-l.1 for 
A/Thy-1.1 mice and anti-Thy-l.2 for other mice in this table, all of which are Thy-l.2). 
:~ These data come from the experiments summarized in Table I; each line corresponds to a 
line in Table I, negative controls and entries for TL antiserum omitted. The range of values 
quoted indicates results obtained in more than one test. 
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nu/nu  mice  accounts  for  the  approximately  50%  reduction  in  the  relative 
proportions of C and D  layer spleen cells and the corresponding increase in the 
relative proportions of A  and B  layer spleen  cells,  in comparison with normal 
mice (Table II). 
Induction of Cells from Embryo Liver.--As the thymus is thus seen to be un- 
necessary, for the development of inducible potential  T  lymphocytes, it is not 
surprising that there was a high rate of induction of T  lymphocytes from fetal 
liver  cells  (<34%  for  the  B  layer)  at  the  14-day  stage  of  embryogenesis 
(Table  I),  the  earliest  time  at  which  T  lymphocytes can  be  detected  in  the 
thymus  (4,  5).  "TI"  cells,  probably  the  first  T  cells  to  appear  in  peripheral 
lymphoid tissue, have the ability to cooperate with B  cells in humoral immune 
responses  (6)  but  no  T  cell  function  has  been  demonstrable  in  mouse  liver 
before birth (7), so it is hardly likely that the 14-day liver contains any thymus- 
processed ceils  (also see particularly references 8 and 9). 
SUMMARY 
A product of mouse thymus induces cells found in the spleen  and bone mar- 
row  of nu/nu mice  (which  lack  a  thymus),  and  in  14-day embryonic mouse 
liver,  to differentiate in vitro into T  lymphocytes (defined as ceils bearing TL 
and  Thy-1  antigens).  Thus  the  in  vitro  T  lymphocyte induction  mechanism 
acts on a  cell that is antecedent  to any thymus-mediated process. 
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